Pharmex Group is an international pharmaceutical company with operational headquarters in Madrid, Spain, and a manufacturing facility in Córdoba.

Company Profile

The Pharmex Group specializes in the development, manufacturing, and commercialization of a wide range of healthcare products, from branded generics to food supplements and cosmetics. The company operates internationally with global headquarters in Geneva, Switzerland, and a significant manufacturing presence in Southern Spain.

History:
The group was established in October 2016 when Pharmex S.A. (Switzerland) acquired the portfolio and manufacturing plant of the historical Spanish company Laboratorios Pérez Giménez, founded in 1930.

Core Business:
Pharmex positions itself as a competitive partner for contract manufacturing (CDMO services) in addition to developing its own branded product lines.

Manufacturing Capabilities:
The company operates a large, EUGMP certified facility spanning 65,000 m² in Córdoba, Spain, which allows for the simultaneous manufacturing of various product types, including large-volume oral solids, suppositories, and semi-solids.

Product Focus:
Their portfolio is diversified across several health and wellness categories:

Healthcare/Medicines:
Development and marketing of high-quality branded generic drugs.

Infant Nutrition:
Produces a variety of infant formulas, jars, and cereals under the brand name Tebramil®.

Food Supplements/OTC:
Offers various food supplements and over-the-counter products, including the specific products listed in your query, which fall under the Pharmexmer and Cesarbiotic brands.

Cosmetics:
Involved in the development of dermocosmetic brands.

Global Reach:
The company emphasizes expansion into European, Middle Eastern, African, and Latin American markets.